COVID-19 Resources
COVAX Humanitarian Buffer
The IASC successfully advocated with GAVI for the establishment of a COVAX humanitarian ‘buffer’, to ensure that up to 5 per cent of the COVID-19 vaccine doses procured through the COVAX facility will serve as a contingency stock for at-risk vulnerable populations in humanitarian settings. Experience shows that even for routine vaccinations, and despite governments’ best efforts, some people inevitably fall through the cracks. Therefore, in support of national government obligations, the IASC has continued to advocate for vulnerable populations to be part of planning processes.
Appeals and Progress Reports
More info on previous appeals and progress reports can be found here.